نتایج جستجو برای: neutralizing antibodies

تعداد نتایج: 168595  

Journal: :Science 2011
Johannes F Scheid Hugo Mouquet Beatrix Ueberheide Ron Diskin Florian Klein Thiago Y K Oliveira John Pietzsch David Fenyo Alexander Abadir Klara Velinzon Arlene Hurley Sunnie Myung Farid Boulad Pascal Poignard Dennis R Burton Florencia Pereyra David D Ho Bruce D Walker Michael S Seaman Pamela J Bjorkman Brian T Chait Michel C Nussenzweig

Passive transfer of broadly neutralizing HIV antibodies can prevent infection, which suggests that vaccines that elicit such antibodies would be protective. Thus far, however, few broadly neutralizing HIV antibodies that occur naturally have been characterized. To determine whether these antibodies are part of a larger group of related molecules, we cloned 576 new HIV antibodies from four unrel...

Journal: :Infection and immunity 1980
T Tamura S Chiba Y Chiba T Nakao

The local secretory immune mechanism in infants with cytomegalovirus infection was studied by a measurement of neutralizing antibody in saliva. Neutralizing antibodies were determined by the microculture plaque assay in 65 saliva specimens including 54 samples from cytomegalovirus-infected subjects and 11 from seronegative controls. In addition, cytomegalovirus isolation from saliva or urine or...

Journal: :Journal of virology 2002
M Ostrowski J A Galeota A M Jar K B Platt F A Osorio O J Lopez

After infection of swine with porcine reproductive and respiratory syndrome virus (PRRSV), there is a rapid rise of PRRSV-specific nonneutralizing antibodies (NNA), while neutralizing antibodies (NA) are detectable not sooner than 3 weeks later. To characterize neutralizing epitopes, we selected phages from a 12-mer phage display library using anti-PRRSV neutralizing monoclonal antibody (MAb) I...

Journal: :Clinical and vaccine immunology : CVI 2016
Wei Bu Gregory M Hayes Hui Liu Lorraine Gemmell David O Schmeling Pierce Radecki Fiona Aguilar Peter D Burbelo Jennifer Woo Henry H Balfour Jeffrey I Cohen

Prospective studies of antibodies to multiple Epstein-Barr virus (EBV) proteins and EBV neutralizing antibodies in the same individuals before, during, and after primary EBV infection have not been reported. We studied antibody responses to EBV in college students who acquired primary EBV infection during prospective surveillance and correlated the kinetics of antibody response with the severit...

Journal: :Human vaccines 2011
Joachim Denner

Although the development of an effective vaccine is the main goal in the fight against AIDS, all attempts by numerous laboratories to develop a vaccine have failed so far. In addition, it is still unclear whether cytotoxic T cells or neutralizing antibodies or both should be induced. The major advantage of neutralizing antibodies is their ability to prevent infection and subsequent integration ...

2010
John Pietzsch Johannes F. Scheid Hugo Mouquet Florian Klein Michael S. Seaman Mila Jankovic Davide Corti Antonio Lanzavecchia Michel C. Nussenzweig

The identification and characterization of conserved epitopes on the HIV-1 viral spike that are immunogenic in humans and targeted by neutralizing antibodies is an important step in vaccine design. Antibody cloning experiments revealed that 32% of all HIV-neutralizing antibodies expressed by the memory B cells in patients with high titers of broadly neutralizing antibodies recognize one or more...

2011
Margaret J. Hosie Daniela Pajek Ayman Samman Brian J. Willett

One of the major obstacles that must be overcome in the design of effective lentiviral vaccines is the ability of lentiviruses to evolve in order to escape from neutralizing antibodies. The primary target for neutralizing antibodies is the highly variable viral envelope glycoprotein (Env), a glycoprotein that is essential for viral entry and comprises both variable and conserved regions. As a r...

Journal: :Protein engineering, design & selection : PEDS 2004
R Pantophlet I A Wilson D R Burton

In an attempt to design immunogens that elicit broadly HIV-neutralizing antibodies, we recently engineered monomeric HIV-1 gp120 to bind preferentially b12, a broadly neutralizing antibody to the CD4-binding site (CD4bs) on gp120, by mutating four central residues in the CD4bs to alanine and introducing extra N-glycosylation sites potentially to mask unwanted B-cell epitopes. Despite the favora...

2014
Anne-Sophie Dugast Ying Chan Michelle Hoffner Anna Licht Joseph Nkolola Hualin Li Hendrik Streeck Todd J. Suscovich Musie Ghebremichael Margaret E. Ackerman Dan H. Barouch Galit Alter

Recent immune correlates analysis from the RV144 vaccine trial has renewed interest in the role of non-neutralizing antibodies in mediating protection from infection. While neutralizing antibodies have proven difficult to induce through vaccination, extra-neutralizing antibodies, such as those that mediate antibody-dependent cellular cytotoxicity (ADCC), are associated with long-term control of...

2017
Anna Bootz Astrid Karbach Johannes Spindler Barbara Kropff Nina Reuter Heinrich Sticht Thomas H Winkler William J Britt Michael Mach

Human cytomegalovirus (HCMV) is an important, ubiquitous pathogen that causes severe clinical disease in immunocompromised individuals, such as organ transplant recipients and infants infected in utero. Antiviral chemotherapy remains problematic due to toxicity of the available compounds and the emergence of viruses resistant to available antiviral therapies. Antiviral antibodies could represen...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید